Systemic Vitamin D Supplementation in Dental Implants Patients
VitaminD
1 other identifier
interventional
135
1 country
3
Brief Summary
Vitamin D plays an essential role in calcium homeostasis and is critical for bone formation and remodeling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Oct 2012
Typical duration for phase_4
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 20, 2015
CompletedFirst Posted
Study publicly available on registry
October 21, 2015
CompletedOctober 22, 2015
October 1, 2015
1 year
October 20, 2015
October 21, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
25 OH Serum levels
VIT D Serum levels
2 years
Secondary Outcomes (1)
Osteoporosis condition
2 years
Study Arms (1)
Vit D
OTHERVit D 20 mg/day
Interventions
Eligibility Criteria
You may qualify if:
- \- Menopause patients
You may not qualify if:
- patients with a past history of neurological disorder;
- who had received pharmacotherapy for depression within 8 weeks of screening;
- who were taking medication known to interfere with Vit D;
- who had recent psychiatricor systemic illness;
- uncontrolled hypertension (blood pressure \> 160/95mmHg);
- unstable cardiovascular disease;
- User of psychoactive medications;
- alcohol excess consumption abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Gynelogical Center
Fortaleza, Ceará, 60115-191, Brazil
University Potiguar
Natal, Rio Grande do Norte, 59060, Brazil
Marco Botelho
São Paulo, São Paulo, 04023-062, Brazil
Related Publications (2)
Botelho MA, Queiroz DB, Barros G, Guerreiro S, Fechine P, Umbelino S, Lyra A, Borges B, Freitas A, Queiroz DC, Ruela R, Almeida JG, Quintans L Jr. Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study. Clinics (Sao Paulo). 2014 Feb;69(2):75-82. doi: 10.6061/clinics/2014(02)01.
PMID: 24519196RESULTBotelho MA, Martins JG, Ruela RS, Queiroz DB, Ruela WS. Nanotechnology in ligature-induced periodontitis: protective effect of a doxycycline gel with nanoparticules. J Appl Oral Sci. 2010 Jul-Aug;18(4):335-42. doi: 10.1590/s1678-77572010000400003.
PMID: 20835566RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gugliemo G Campus, PhD
Università degli Studi di Sassari
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Program Director of Graduate Biotechnology
Study Record Dates
First Submitted
October 20, 2015
First Posted
October 21, 2015
Study Start
October 1, 2012
Primary Completion
October 1, 2013
Study Completion
October 1, 2015
Last Updated
October 22, 2015
Record last verified: 2015-10